(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are ParkerVision, Peoples Financial Corporation, and American Public Education.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | ParkerVision (PRKR) | 0.20 | 33.33% | 2023-11-22 23:46:06 |
| 2 | Peoples Financial Corporation (PFBX) | 16.00 | 18.52% | 2023-11-22 21:07:05 |
| 3 | American Public Education (APEI) | 6.67 | 15.8% | 2023-11-23 12:10:41 |
| 4 | NeuroMetrix (NURO) | 4.24 | 12.81% | 2023-11-23 12:50:52 |
| 5 | Reading International (RDIB) | 13.73 | 10.73% | 2023-11-23 07:07:06 |
| 6 | Sify Technologies Limited (SIFY) | 1.60 | 8.11% | 2023-11-23 15:06:05 |
| 7 | MicroVision (MVIS) | 2.43 | 7.05% | 2023-11-23 08:14:01 |
| 8 | Trip.com (TCOM) | 34.93 | 6.56% | 2023-11-23 12:17:15 |
| 9 | ImmunoGen (IMGN) | 16.14 | 6.11% | 2023-11-23 12:13:03 |
| 10 | Rocky Brands (RCKY) | 26.96 | 6.06% | 2023-11-23 05:13:06 |
The three biggest losers today are RiceBran Technologies, Niu Technologies, and Origin Agritech Limited.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | RiceBran Technologies (RIBT) | 0.15 | -11.45% | 2023-11-23 07:46:06 |
| 2 | Niu Technologies (NIU) | 2.39 | -7% | 2023-11-23 12:16:40 |
| 3 | Origin Agritech Limited (SEED) | 2.54 | -6.98% | 2023-11-23 13:08:09 |
| 4 | Autodesk (ADSK) | 202.66 | -6.9% | 2023-11-23 12:50:12 |
| 5 | Virgin Galactic (SPCE) | 1.99 | -6.57% | 2023-11-23 13:00:28 |
| 6 | Patriot National Bancorp (PNBK) | 4.95 | -5.71% | 2023-11-22 23:06:06 |
| 7 | Gyrodyne (GYRO) | 8.95 | -5.69% | 2023-11-23 12:12:47 |
| 8 | Regulus Therapeutics (RGLS) | 1.30 | -5.11% | 2023-11-23 07:44:05 |
| 9 | Pixelworks (PXLW) | 1.12 | -4.27% | 2023-11-23 02:23:05 |
| 10 | Sangamo Therapeutics (SGMO) | 0.36 | -4.15% | 2023-11-23 13:23:06 |
Winners today
1. ParkerVision (PRKR) – 33.33%
ParkerVision, Inc. develops and markets radio frequency technologies and integrated circuits for use in wireless communication products. The company was incorporated in 1989 and is headquartered in Jacksonville, Florida.
NASDAQ ended the session with ParkerVision jumping 33.33% to $0.20 on Friday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, ParkerVision has a trailing twelve months EPS of $0.02.
PE Ratio
ParkerVision has a trailing twelve months price to earnings ratio of 10. Meaning, the purchaser of the share is investing $10 for every dollar of annual earnings.
Volume
Today’s last reported volume for ParkerVision is 271268 which is 154.36% above its average volume of 106646.
Moving Average
ParkerVision’s worth is way higher than its 50-day moving average of $0.09 and way above its 200-day moving average of $0.11.
Yearly Top and Bottom Value
ParkerVision’s stock is valued at $0.20 at 01:32 EST, way below its 52-week high of $0.54 and way higher than its 52-week low of $0.07.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ParkerVision’s EBITDA is 0.76.
More news about ParkerVision.
2. Peoples Financial Corporation (PFBX) – 18.52%
Peoples Financial Corporation operates as the bank holding company for The Peoples Bank that provides banking, financial, and trust services to government entities, individuals, and small and commercial businesses in Mississippi. It accepts various deposits, such as interest and non-interest bearing checking accounts, savings accounts, certificates of deposit, and individual retirement accounts (IRAs). The company also offers business, commercial, real estate, construction, personal, and installment loans; and personal trust, agencies, and estate services, including living and testamentary trusts, executorships, guardianships, and conservatorships. In addition, it provides self-directed IRAs; and escrow management, stock transfer, and bond paying agency accounts to corporate customers. Further, the company offers various other services consisting of safe deposit box rental, wire transfer, night drop facilities, collection, cash management, and internet banking services. As of December 31, 2021, the company operated through 17 branches located in Harrison, Hancock, Jackson, and Stone counties. It also has 28 automated teller machines at its branch locations, as well as other off-site and non-proprietary locations. The company was founded in 1896 and is headquartered in Biloxi, Mississippi.
NASDAQ ended the session with Peoples Financial Corporation jumping 18.52% to $16.00 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Peoples Financial Corporation has a trailing twelve months EPS of $2.69.
PE Ratio
Peoples Financial Corporation has a trailing twelve months price to earnings ratio of 5.95. Meaning, the purchaser of the share is investing $5.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.57%.
Yearly Top and Bottom Value
Peoples Financial Corporation’s stock is valued at $16.00 at 01:32 EST, way below its 52-week low of $11.50.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 33.95M for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 9, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 2.22%.
Volume
Today’s last reported volume for Peoples Financial Corporation is 3035 which is 36.09% above its average volume of 2230.
More news about Peoples Financial Corporation.
3. American Public Education (APEI) – 15.8%
American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.
NASDAQ ended the session with American Public Education jumping 15.8% to $6.67 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, American Public Education has a trailing twelve months EPS of $-3.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.4%.
Yearly Top and Bottom Value
American Public Education’s stock is valued at $6.67 at 01:32 EST, way below its 52-week high of $14.22 and way above its 52-week low of $3.76.
Volatility
American Public Education’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.64%, a positive 1.34%, and a positive 3.46%.
American Public Education’s highest amplitude of average volatility was 2.54% (last week), 4.98% (last month), and 3.46% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
American Public Education’s EBITDA is 0.37.
Volume
Today’s last reported volume for American Public Education is 72302 which is 55.31% above its average volume of 46553.
More news about American Public Education.
4. NeuroMetrix (NURO) – 12.81%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix jumping 12.81% to $4.24 on Friday, following the last session’s upward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-5.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.61%.
More news about NeuroMetrix.
5. Reading International (RDIB) – 10.73%
Reading International, Inc., together with its subsidiaries, focuses on the ownership, development, and operation of entertainment and real property assets in the United States, Australia, and New Zealand. The company operates in two segments, Cinema Exhibition and Real Estate. The Cinema Exhibition segment operates multiplex cinemas. This segment operates its cinema exhibition businesses under the Reading Cinemas, Angelika Film Center, Consolidated Theatres, State Cinema, Event Cinemas, and Rialto Cinemas brands. The Real Estate segment develops, rents, or licenses retail, commercial, and live theater assets. As of December 31, 2020, the company had interests in 63 cinemas comprising approximately 515 screens; fee interests in two live theaters; fee interest in 44 Union Square property; fee interest in one cinema in Manhattan; fee interests in two cinemas in Australia and three cinemas in New Zealand; fee interest in entertainment-themed centers; fee interest in 2 office buildings; and fee ownership of approximately 8.9 million square feet of developed and undeveloped real estate assets. Reading International, Inc. was incorporated in 1999 and is headquartered in New York, New York.
NASDAQ ended the session with Reading International rising 10.73% to $13.73 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Reading International has a trailing twelve months EPS of $-1.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.71%.
Volume
Today’s last reported volume for Reading International is 15532 which is 133.03% above its average volume of 6665.
Moving Average
Reading International’s value is below its 50-day moving average of $14.36 and way below its 200-day moving average of $19.32.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Reading International’s EBITDA is 2.06.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30%, now sitting on 224.63M for the twelve trailing months.
More news about Reading International.
6. Sify Technologies Limited (SIFY) – 8.11%
Sify Technologies Limited provides integrated ICT solutions and services in India and internationally. It operates through Network Centric Services, Data Center Services, and Digital Services segments. The Network Centric Services segment offers internet, internet protocol and multi-protocol label switching virtual private network, SDWAN, managed Wi-Fi, internet of things, wholesale and retail voice, managed services, dedicated internet access, and proactive monitoring and management of the network and devices. The Data Center Services segment provides co-location services; and managed data center services, such as storage and back-up management, performance monitoring, infrastructure monitoring and management, network availability, server load balancing, managed shared firewall, web server log reporting, and remote and smart hands services. The Digital Services segment offers managed network services; EDGE services; cloud and managed services including cloud and storage solutions, managed services, value added services, domestic and international managed services; and technology integration services include system integration, data centers build, network, security solutions, remote and onsite infrastructure management, managed security services, as well as sale of hardware and software. This segment also offers applications integration services, such as talent management, supply chain management, online assessment, web development, document management, content, digital signature, digital certificate-based authentication, supply chain solutions, content management, sale of digital certificates; and sale, implementation, and maintenance of industry specific applications; supply chain software, and eLearning software development services; and operates web portals. The company was formerly known as Sify Limited and changed its name to Sify Technologies Limited in October 2007. The company was incorporated in 1995 and is headquartered in Chennai, India.
NASDAQ ended the session with Sify Technologies Limited jumping 8.11% to $1.60 on Friday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Sify Technologies Limited has a trailing twelve months EPS of $0.03.
PE Ratio
Sify Technologies Limited has a trailing twelve months price to earnings ratio of 53.33. Meaning, the purchaser of the share is investing $53.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.18%.
Moving Average
Sify Technologies Limited’s value is below its 50-day moving average of $1.66 and below its 200-day moving average of $1.67.
More news about Sify Technologies Limited.
7. MicroVision (MVIS) – 7.05%
MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.
NASDAQ ended the session with MicroVision rising 7.05% to $2.43 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, MicroVision has a trailing twelve months EPS of $-0.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -83.29%.
Volatility
MicroVision’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.74%, a positive 0.85%, and a positive 3.58%.
MicroVision’s highest amplitude of average volatility was 3.90% (last week), 4.35% (last month), and 3.58% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
MicroVision’s EBITDA is 184.05.
Moving Average
MicroVision’s value is way above its 50-day moving average of $2.11 and way under its 200-day moving average of $2.91.
Yearly Top and Bottom Value
MicroVision’s stock is valued at $2.43 at 01:32 EST, way below its 52-week high of $8.20 and way above its 52-week low of $1.82.
More news about MicroVision.
8. Trip.com (TCOM) – 6.56%
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
NASDAQ ended the session with Trip.com rising 6.56% to $34.93 on Friday, following the last session’s upward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $1.34.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 26.07. Meaning, the purchaser of the share is investing $26.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.55%.
Volume
Today’s last reported volume for Trip.com is 12589700 which is 189.65% above its average volume of 4346500.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Trip.com’s EBITDA is 15.17.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Trip.com’s stock is considered to be overbought (>=80).
More news about Trip.com.
9. ImmunoGen (IMGN) – 6.11%
ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen jumping 6.11% to $16.14 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.88%.
More news about ImmunoGen.
10. Rocky Brands (RCKY) – 6.06%
Rocky Brands, Inc. designs, manufactures, and markets footwear and apparel under the Rocky, Georgia Boot, Durango, Lehigh, Muck, XTRATUF, Servus, NEOS, Ranger, and licensed Michelin brand names in the United States, Canada, and internationally. It operates through Wholesale, Retail, and Contract Manufacturing segments. The Wholesale segment offers products in approximately 10,000 retail locations through a range of distribution channels comprising sporting goods stores, outdoor retailers, independent shoe retailers, hardware stores, catalogs, mass merchants, uniform stores, farm store chains, specialty safety stores, and specialty and online retailers. The Retail segment sells its products directly to consumers through its e-commerce websites, including rockyboots.com, georgiaboot.com, durangoboot.com, lehighoutfitters.com, lehighsafetyshoes.com, slipgrips.com,muckbootcompany.com,xtratuf.com, and Rocky outlet store in Nelsonville, Ohio, and retail stores. The Contract Manufacturing segment include private label sales and any sales to customers which are contracted to manufacture a specific footwear product for a customer and include sales to the U.S. Military. It serves industrial and construction workers, as well as workers in the hospitality industry, such as restaurants or hotels; farmers and ranchers; consumers enamored with western influenced fashion; commercial military personnel; hunting, fishing, camping, and hiking enthusiasts; law enforcement, security personnel, and postal employees; and for the U.S. military personnel. Rocky Brands, Inc. was founded in 1932 and is headquartered in Nelsonville, Ohio.
NASDAQ ended the session with Rocky Brands rising 6.06% to $26.96 on Friday, following the last session’s upward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Rocky Brands has a trailing twelve months EPS of $1.39.
PE Ratio
Rocky Brands has a trailing twelve months price to earnings ratio of 19.4. Meaning, the purchaser of the share is investing $19.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.8%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 14.8%, now sitting on 474.81M for the twelve trailing months.
Volume
Today’s last reported volume for Rocky Brands is 132274 which is 167.78% above its average volume of 49396.
Sales Growth
Rocky Brands’s sales growth is negative 5.3% for the current quarter and 8.5% for the next.
Previous days news about Rocky Brands
- Can rocky brands (rcky) run higher on rising earnings estimates?. According to Zacks on Tuesday, 21 November, "Over the last 30 days, one estimate has moved higher for Rocky Brands compared to no negative revisions. ", "Thanks to promising estimate revisions, Rocky Brands currently carries a Zacks Rank #1 (Strong Buy). "
- Bull of the day: rocky brands (rcky). According to Zacks on Wednesday, 22 November, "With the holiday shopping season beginning, Rocky Brands stock is very attractive and now may be an ideal time to buy RCKY shares after the company’s very impressive Q3 report showed increased profitability, product improvement, and reduced inventory.", "Soaring Earnings Estimates: Alluding to more upside in Rocky Brands stock is that annual earnings estimates have soared over the last 30 days. "
More news about Rocky Brands.
Losers Today
1. RiceBran Technologies (RIBT) – -11.45%
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.
NASDAQ ended the session with RiceBran Technologies dropping 11.45% to $0.15 on Friday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, RiceBran Technologies has a trailing twelve months EPS of $-1.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -93.64%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RiceBran Technologies’s EBITDA is -8.13.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 41.16M for the twelve trailing months.
Moving Average
RiceBran Technologies’s value is way under its 50-day moving average of $0.35 and way below its 200-day moving average of $0.79.
Sales Growth
RiceBran Technologies’s sales growth is 48.4% for the present quarter and 32% for the next.
More news about RiceBran Technologies.
2. Niu Technologies (NIU) – -7%
Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Niu Technologies sliding 7% to $2.39 on Friday, following the last session’s downward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.44%.
Moving Average
Niu Technologies’s worth is way below its 50-day moving average of $2.72 and way under its 200-day moving average of $3.78.
More news about Niu Technologies.
3. Origin Agritech Limited (SEED) – -6.98%
Origin Agritech Limited, together with its subsidiaries, operates an agricultural biotechnology and an e-commerce platform in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as develops hybrid seed technology. The company also operates an e-commerce platform, which provides range of products, including agricultural seed products that comprise corn, rice, and vegetable seeds; other agricultural inputs, such as fertilizers and agricultural chemicals; foods; household products; and other consumer products to farmers through online and mobile ordering. It has a collaboration agreement with Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China.
NASDAQ ended the session with Origin Agritech Limited sliding 6.98% to $2.54 on Friday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Origin Agritech Limited has a trailing twelve months EPS of $-0.21.
More news about Origin Agritech Limited.
4. Autodesk (ADSK) – -6.9%
Autodesk, Inc. provides 3D design, engineering, and entertainment technology solutions worldwide. The company offers AutoCAD Civil 3D, a surveying, design, analysis, and documentation solution for civil engineering, including land development, transportation, and environmental projects; BuildingConnected, a SaaS preconstruction solution; AutoCAD, a software for professional design, drafting, detailing, and visualization; AutoCAD LT, a drafting and detailing software; computer-aided manufacturing (CAM) software for computer numeric control machining, inspection, and modelling for manufacturing; Fusion 360, a 3D CAD, CAM, and computer-aided engineering tool; and Industry Collections tools for professionals in architecture, engineering and construction, product design and manufacturing, and media and entertainment collection industries. It also provides Inventor tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; Vault, a data management software to manage data in one central location, accelerate design processes, and streamline internal/external collaboration; Maya and 3ds Max software products that offer 3D modeling, animation, effects, rendering, and compositing solutions; and ShotGrid, a cloud-based software for review and production tracking in the media and entertainment industry. It sells its products and services to customers directly, as well as through a network of resellers and distributors. Autodesk, Inc. was incorporated in 1982 and is headquartered in San Francisco, California.
NASDAQ ended the session with Autodesk falling 6.9% to $202.66 on Friday, after two sequential sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Autodesk has a trailing twelve months EPS of $4.03.
PE Ratio
Autodesk has a trailing twelve months price to earnings ratio of 50.29. Meaning, the purchaser of the share is investing $50.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 89.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 5.21B for the twelve trailing months.
Volatility
Autodesk’s last week, last month’s, and last quarter’s current intraday variation average was 0.41%, 0.42%, and 1.28%.
Autodesk’s highest amplitude of average volatility was 1.03% (last week), 1.31% (last month), and 1.28% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Autodesk’s stock is considered to be overbought (>=80).
Previous days news about Autodesk
- Autodesk (adsk) reports Q3 earnings: what key metrics have to say. According to Zacks on Tuesday, 21 November, "For the quarter ended October 2023, Autodesk (ADSK Quick QuoteADSK – Free Report) reported revenue of $1.41 billion, up 10.5% over the same period last year. ", "Here is how Autodesk performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Autodesk.
5. Virgin Galactic (SPCE) – -6.57%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic sliding 6.57% to $1.99 on Friday while NYSE rose 0.29% to $15,907.89.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -90.56%.
Sales Growth
Virgin Galactic’s sales growth is 244.1% for the ongoing quarter and 66.4% for the next.
Previous days news about Virgin Galactic
- : Virgin Galactic stock on pace to snap two-day winning streak. According to MarketWatch on Tuesday, 21 November, "Shares of Virgin Galactic Holdings Inc. SPCE are down 5.1% Tuesday, putting the stock on pace to snap a two-day winning streak. "
More news about Virgin Galactic.
6. Patriot National Bancorp (PNBK) – -5.71%
Patriot National Bancorp, Inc. operates as the holding company for Patriot Bank, N.A. that provides community banking services to individuals, small and medium-sized businesses, and professionals. The company accepts consumer and commercial deposit accounts, such as checking, interest-bearing negotiable order of withdrawal, money market, savings, prepaid deposit, on-line national money market, individual retirement accounts, and health savings accounts, as well as certificate of deposit account registry service. Its loan portfolio comprises commercial real estate, commercial business, small business administration, construction, purchased residential real estate, and various consumer loans. The company also offers automated clearing house transfers, lockbox, Internet banking, bill payment, remote deposit capture, debit card, money order, traveler's check, and automatic teller machine services. It operated through a network of eight branch offices located in Fairfield and New Haven Counties, Connecticut; and one branch offices located in Westchester County, New York. The company was founded in 1994 and is headquartered in Stamford, Connecticut.
NASDAQ ended the session with Patriot National Bancorp dropping 5.71% to $4.95 on Friday, after two sequential sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Patriot National Bancorp has a trailing twelve months EPS of $-0.84.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.76%.
Moving Average
Patriot National Bancorp’s value is way under its 50-day moving average of $6.70 and way under its 200-day moving average of $8.32.
Yearly Top and Bottom Value
Patriot National Bancorp’s stock is valued at $4.95 at 01:32 EST, way under its 52-week high of $12.00 and higher than its 52-week low of $4.55.
Revenue Growth
Year-on-year quarterly revenue growth declined by 69%, now sitting on 26.35M for the twelve trailing months.
More news about Patriot National Bancorp.
7. Gyrodyne (GYRO) – -5.69%
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
NASDAQ ended the session with Gyrodyne dropping 5.69% to $8.95 on Friday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Gyrodyne has a trailing twelve months EPS of $0.2.
PE Ratio
Gyrodyne has a trailing twelve months price to earnings ratio of 44.75. Meaning, the purchaser of the share is investing $44.75 for every dollar of annual earnings.
Yearly Top and Bottom Value
Gyrodyne’s stock is valued at $8.95 at 01:32 EST, way below its 52-week high of $12.66 and way above its 52-week low of $7.80.
Moving Average
Gyrodyne’s worth is way below its 50-day moving average of $10.54 and below its 200-day moving average of $9.51.
More news about Gyrodyne.
8. Regulus Therapeutics (RGLS) – -5.11%
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
NASDAQ ended the session with Regulus Therapeutics falling 5.11% to $1.30 on Friday, after three consecutive sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Regulus Therapeutics has a trailing twelve months EPS of $-1.59.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -84.71%.
Yearly Top and Bottom Value
Regulus Therapeutics’s stock is valued at $1.30 at 01:32 EST, way under its 52-week high of $2.14 and way above its 52-week low of $0.76.
More news about Regulus Therapeutics.
9. Pixelworks (PXLW) – -4.27%
Pixelworks, Inc., together with its subsidiaries, develops and markets semiconductor and software solutions for mobile, home entertainment, content, and business and education markets. The company provides video display processor products, including image processor integrated circuits, such as embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing within high-end display systems; video co-processor integrated circuits that work with an image processor to post-process video signals to enhance the performance or feature set of the overall video solution; and transcoder integrated circuits, which comprise embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing for converting bitrates, resolutions, and codecs. As of March 31, 2022, it had an intellectual property portfolio of 334 patents related to the visual display of digital image data. The company sells its through a direct sales force, distributors, and manufacturers' representatives in Japan, China, Taiwan, the United States, Europe, and Korea. Pixelworks, Inc. was incorporated in 1997 and is based in Portland, Oregon.
NASDAQ ended the session with Pixelworks sliding 4.27% to $1.12 on Friday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Pixelworks has a trailing twelve months EPS of $-0.44.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.38%.
More news about Pixelworks.
10. Sangamo Therapeutics (SGMO) – -4.15%
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
NASDAQ ended the session with Sangamo Therapeutics falling 4.15% to $0.36 on Friday, after two sequential sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.37%.
More news about Sangamo Therapeutics.
Stay up to date with our winners and losers daily report
